Dterminants of medication adherence in Moroccan schzophrenic patients

Patient Preference and Adherence, 2013

Background: Nonadherence is common among patients with schizophrenia, although the rates vary according to means of assessment and patient population. Failure to adhere to medication can have a major impact on the course of illness and treatment outcomes, including increasing the risk of relapse and rehospitalization. Understanding psychiatrists' perception of the causes and consequences of nonadherence is crucial to addressing adherence problems effectively. Methods: The Europe, the Middle East, and Africa (EMEA) Spanish Adherencia Terapéutica en la Esquizofrenia (ADHES) survey was conducted by questionnaire during January-March 2010 among psychiatrists treating patients with schizophrenia in 36 countries. The survey comprised 20 questions. In addition to recording the demographic details of the 4722 respondents (∼12% response rate), it canvassed their preferred methods of assessing adherence, their perceptions of adherence rates, reasons for nonadherence, and strategies to improve adherence. Results: Psychiatrists estimated that 53% of their patients with schizophrenia were partially/ nonadherent during the previous month. They estimated only one-third of patients who deteriorated after stopping medication were able to attribute this to nonadherence. Psychiatrists assessed adherence most often by patient interview. Lack of insight was viewed as the most important cause of medication discontinuation, followed by patients feeling better and thinking their medication unnecessary, and experiencing undesirable side effects. Considerably fewer psychiatrists viewed insufficient efficacy, cognitive impairment, or drug/alcohol abuse as the most important reasons for their patients stopping medication. Conclusion: Psychiatrists throughout EMEA recognize the impact of partial/nonadherence to medication, with patient enquiry being the most commonly used means of assessment. There remains a need for more proactive management of patients with schizophrenia, particularly in increasing patient insight of their illness in order to improve adherence and minimize the consequences of relapse. Strategies focused on raising awareness of the importance of adherence are also warranted, with the aim of improving patient outcomes in schizophrenia.

Patient Preference and Adherence, 2013

Background: Nonadherence is common among patients with schizophrenia, although the rates vary according to means of assessment and patient population. Failure to adhere to medication can have a major impact on the course of illness and treatment outcomes, including increasing the risk of relapse and rehospitalization. Understanding psychiatrists' perception of the causes and consequences of nonadherence is crucial to addressing adherence problems effectively. Methods: The Europe, the Middle East, and Africa (EMEA) Spanish Adherencia Terapéutica en la Esquizofrenia (ADHES) survey was conducted by questionnaire during January-March 2010 among psychiatrists treating patients with schizophrenia in 36 countries. The survey comprised 20 questions. In addition to recording the demographic details of the 4722 respondents (∼12% response rate), it canvassed their preferred methods of assessing adherence, their perceptions of adherence rates, reasons for nonadherence, and strategies to improve adherence. Results: Psychiatrists estimated that 53% of their patients with schizophrenia were partially/ nonadherent during the previous month. They estimated only one-third of patients who deteriorated after stopping medication were able to attribute this to nonadherence. Psychiatrists assessed adherence most often by patient interview. Lack of insight was viewed as the most important cause of medication discontinuation, followed by patients feeling better and thinking their medication unnecessary, and experiencing undesirable side effects. Considerably fewer psychiatrists viewed insufficient efficacy, cognitive impairment, or drug/alcohol abuse as the most important reasons for their patients stopping medication. Conclusion: Psychiatrists throughout EMEA recognize the impact of partial/nonadherence to medication, with patient enquiry being the most commonly used means of assessment. There remains a need for more proactive management of patients with schizophrenia, particularly in increasing patient insight of their illness in order to improve adherence and minimize the consequences of relapse. Strategies focused on raising awareness of the importance of adherence are also warranted, with the aim of improving patient outcomes in schizophrenia.

Schizophrenia is a classic psychiatric diagnosis in which patients experience psychotic symptoms for longer than 6 months. Non adherence is a major problem in the treatment of schizophrenia which is significantly associated with treatment out come and is the major cause of relapse in the treatment of schizophrenia. High prevalence, costs associated with it and potentially severe consequences are those cases that made the study of this phenomenon a priority issue. The objective of this study was to evaluate adherence rates to schizophrenic patients. cross-sectional method was conducted over 2 month period (march 10th to may 15th) in Adama hospital and patients self-reporting using an interview (focusing on how often regular medication doses were missed altogether, and whether they missed taking their doses on time) was used to evaluate adherence rates to schizophrenic medications. Data collected was analyzed using the Statistical Package for the Social Sciences (SPSS) version 20 software, which is used to associate different variables with an adherence. In the study 141 patients were included and on the basis of patients self-report, 56% of patients reported that they had never missed a medication dose, 14.18% sometimes missed their daily doses, 11.35% only missed taking their dose at the specific scheduled time and 18.49% missed both taking their dose at the specific scheduled time and sometimes missed their daily doses. The most common reason for missing medication doses were forgetfulness (43.5%), being busy (17.7%), lack of sufficient information about medication (14.5%) & pill burden (8%). duration of maintenance therapy, social drug Use and medication side effects each had a statistically significant association with medication adherence (p<0.05). It was well observed that medication adherence in this study was low as compared to previous reports. Forgetfulness was the most common reason for missing medication dose. Adherence must therefore be considered when planning treatment strategies with schizophrenic medications, particularly in countries such as Ethiopia.

Global Journal of Health Science, 2021

Schizophrenia is a severe chronic mental illness affecting twenty million people worldwide. Although the incidence of schizophrenia remains low, its prevalence may remain high due to medication non-adherence. Knowing potential factors relating to non-adherence with medication among patients with schizophrenia by investigating existing literature is needed in order to understand the phenomenology of this situation. Therefore, the study aimed to explore the most common factors that affected medication non-adherence in patients with schizophrenia. A systematic review was conducted through a literature search on Cochrane Database of Systematic Reviews, MEDLINE, PsycINFO, EBSCOhost, CINAHL Complete, ERIC, and Allied Health databases published from 1980 to 2021. Database searches were conducted with the terms “non-adherence to medication” “schizophrenia,” and “factors.” Eighty-six articles were found following the first-round search. Then seventy-eight articles were excluded due to irrele...

Current clinical pharmacology, 2012

CITATIONS 9 READS 129 7 authors, including:

Australian &amp; New Zealand Journal of Psychiatry, 2010

Objective: To quantify the factors associated with non-adherence to medication among stable patients suffering from schizophrenia in the context of universal access to care. Methods: This naturalistic, multicentric study was conducted in 15 French public hospitals in a region of south-eastern France during a 1 week period in 2008. All consecutive outpatients with stable schizophrenia were recruited. Adherence was assessed with the 10-item Drug Attitude Inventory (DAI). Measures included socio-demographic characteristics, clinical characteristics, insight using the Scale to assess Unawareness of Mental Disease (SUMD), and therapeutic alliance using the Patient Session Questionnaire (PSQ). Regression models were used to identify the risk factors associated with non-adherence. Results: The study included 291 patients, 30% of whom were considered to be non-adherent. Non-adherence increased with duration of untreated psychosis (DUP) (OR = 1.12, 95%CI = 1.03–1.22), lack of insight only fo...

PLoS ONE, 2015

Background Non-adherence to antipsychotic medication has a negative impact on the course of illness resulting in increased risk of relapse, rehospitalization and suicide, and increased costs to healthcare systems. The objective of this study was to investigate factors associated with medication adherence among patients with schizophrenia at Ayder Referral Hospital and Mekelle Hospital in Mekelle, Tigray region, Northern Ethiopia. Methods The study was a cross-sectional survey in which sociodemographic characteristics, drug attitudes, insight and side effects were measured and explored in terms of their relationship with medication adherence. A structured questionnaire as a data collection tool was used. Data were analyzed with the help of SPSS Version 20.0.

Fourth International Conference On Advances In Economics, Social Science and Human Behaviour Study - ESSHBS 2016, 2016

Background: Medication adherence is important to help prevent relapse for patients with schizophrenia who need long term care.

Journal of Universal College of Medical Sciences

INTRODUCTION: Non-compliance to medication in Schizophrenia is a common problem. It leads to frequent recurrence of Psychosis which has negative impact on individuals and their families. Understanding and reducing non-adherence is therefore a key challenge to quality care for patients with Schizophrenia. This study was conducted with the aim of determining the incidence and factors associated with medication non-compliance among patients suffering from schizophrenia. MATERIAL AND METHODS: This cross-sectional study included 94 schizophrenic subjects who visited psychiatric OPD of tertiary level hospital. Disproportionate stratified random sampling method was applied to collect the data. Socio-demographic data sheet, data sheet to collect the various factors of compliance and the 8-item Morisky Medication Adherence Scale (MMAS-8) were used for data collection by interview method. RESULTS: The prevalence of non-compliance was 89.4%. With regards to association between noncompliance ...

South African Journal of Psychiatry, 2018

Background: Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major problem among schizophrenia patients. The purpose of this study was to assess the magnitude and factors associated with antipsychotic medication non-adherence among schizophrenia patients in Amanuel Mental Specialized Hospital. Method: An institution-based cross-sectional study was conducted among 412 people with schizophrenia at Amanuel Mental Specialized Hospital from April to May 2014. Non-adherence was assessed using the questionnaire of Morisky medication adherence rating scale and semi- structured questions for assessment of associated factors. Logistic regression analysis was used to assess predictors of non-adherence. Results: Prevalence of non-adherence was 41.0% among schizophrenia patients. Living in rural areas (adjusted odds ratio [AOR] = 2.07; 95% confidence interval [CI]: 1.31, 3.28), current substance use (AOR = 1.67; 95% CI: 1.09, 2.56), long duration of treatment (AOR = 2.07; 95% CI: 1.22, 3.50) and polypharmacy (AOR = 2.13; 95% CI: 1.34, 3.40) were found to be significantly associated with non-adherence. Conclusion: The results indicate that non-adherence to antipsychotic medication was a major problem among patients with schizophrenia. Reducing the number of antipsychotic medications and availing drugs in rural areas may decrease the level of non-adherence.